Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine + Cytarabine vs Cytarabine in Relapsed/Refractory AML
NCT00317642Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2006
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
A Phase 3 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Sanofi. Started Aug 2006; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00317642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317642.